To Study the Nutri-Genomic Response of Vit-D Supplementation in African-Americans

NACompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

July 31, 2018

Conditions
Hypovitaminosis D
Interventions
DRUG

25 Hydroxy- Vitamin D3 [25 (OH) D3]

Two 50,000 IU tablets of oral Vitamin D3 \[also known as cholecalciferol or 25 hydroxy-Vitamin D3 or 25 (OH) D3\] will be given at baseline and 2 weeks after the baseline visit under direct observation by the nurse or research coordinator.

DRUG

Placebo

Trial Locations (1)

90059

Charles Drew University, Los Angeles

All Listed Sponsors
collaborator

Morehouse School of Medicine

OTHER

collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

lead

Charles Drew University of Medicine and Science

OTHER

NCT02802449 - To Study the Nutri-Genomic Response of Vit-D Supplementation in African-Americans | Biotech Hunter | Biotech Hunter